Torthaí cuardaigh - Conleth G. Murphy

  • 1 - 12 toradh as 12 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    The Role of CDK4/6 Inhibitors in Breast Cancer

    The Role of CDK4/6 Inhibitors in Breast Cancer de réir Conleth G. Murphy

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    HER2 breast cancer therapies: a review

    HER2 breast cancer therapies: a review de réir Shanu Modi, Conleth G. Murphy

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    The Role of CDK4/6 Inhibition in Breast Cancer

    The Role of CDK4/6 Inhibition in Breast Cancer de réir Conleth G. Murphy, Maura N. Dickler

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies

    Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies de réir Conleth G. Murphy, Maura N. Dickler

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells

    PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells de réir Shuhei Ito, Conleth G. Murphy, Ekaterina Doubrovina, Maria Jasin, Mary Ellen Moynahan

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Cancer‐related fatigue and self‐care agency: A multicentre survey of patients receiving chemotherapy

    Cancer‐related fatigue and self‐care agency: A multicentre survey of patients receiving chemotherapy de réir Patricia O’Regan, Géraldine McCarthy, Séamus O’Reilly, Derek G. Power, Brian Bird, Conleth G. Murphy, Josephine Hegarty

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer

    Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer de réir Conleth G. Murphy, Divya Mallam, Samantha Stein, Sujata Patil, Jane Howard, Nancy T. Sklarin, Clifford A. Hudis, Mary L. Gemignani, Andrew D. Seidman

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study

    Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study de réir Aki Morikawa, David M. Peereboom, Helen R. Thorsheim, Ramakrishna Samala, Rajiv Balyan, Conleth G. Murphy, Paul R. Lockman, Ahkeem James Simmons, Robert J. Weil, Viviane Tabar, Patricia S. Steeg, Quentin R. Smith, Andrew D. Seidman

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial

    Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the S... de réir Robert L. Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, Philipp Harter, Conleth G. Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A. Matulonis

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

    Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study de réir Ursula A. Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo, Philipp Harter, Conleth G. Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L. Coleman

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)

    FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) w... de réir Kathleen N. Moore, Amit M. Oza, Nicoletta Colombo, Ana Oaknin, Giovanni Scambia, Domenica Lorusso, Robin Farias‐Eisner, Susana Banerjee, Conleth G. Murphy, János L. Tanyi, Hal W. Hirte, Jason Konner, Peter Lim, Monica Prasad Hayes, Bradley J. Monk, S. Kim, Jiao Wang, Patricia Pautier, I. Vergote, Michael J. Birrer

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

    Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I de réir Kathleen N. Moore, Amit M. Oza, Nicoletta Colombo, Ana Oaknin, Giovanni Scambia, Domenica Lorusso, Gottfried E. Konecny, Susana Banerjee, Conleth G. Murphy, János L. Tanyi, Hal W. Hirte, Jason Konner, Peter Lim, Monica Prasad-Hayes, Bradley J. Monk, Patricia Pautier, Jiao Wang, Anna Berkenblit, Ignace Vergote, Michael J. Birrer

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: